APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Haemophilus Influenzae Type B Vaccine

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Haemophilus Influenzae Type B Vaccine Market Analysis and Forecast 2026-2032

Report ID 173996700222 December 2025193 pages

Choose your research edition.

Industry ResearchHaemophilus Influenzae Type B Vaccine Industry Research Report 2026118 pages · $2,950 USDIndustry Growth & TrendsGlobal Haemophilus Influenzae Type B Vaccine Industry Growth and Trends Forecast to 203298 pages · $3,450 USDMarket StructureGlobal Haemophilus Influenzae Type B Vaccine Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032182 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Haemophilus Influenzae Type B Vaccine Market Outlook and Growth Opportunities 2026198 pages · $4,250 USDMarket Analysis & ForecastGlobal Haemophilus Influenzae Type B Vaccine Market Analysis and Forecast 2026-2032193 pages · $4,950 USD

Market perspective

The global Haemophilus Influenzae Type B Vaccine market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Haemophilus Influenzae Type B Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Haemophilus Influenzae Type B Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Haemophilus Influenzae Type B Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Haemophilus Influenzae Type B Vaccine is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Haemophilus Influenzae Type B Vaccine include Takeda Pharmaceuticals Company, Sanofi, Novartis, Merck, Lanzhou Institute of Biologica, GlaxoSmithKline, Walvax Biotechnology and Immunize BC, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Haemophilus Influenzae Type B Vaccine, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Haemophilus Influenzae Type B Vaccine, also provides the sales of main regions and countries. Of the upcoming market potential for Haemophilus Influenzae Type B Vaccine, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Haemophilus Influenzae Type B Vaccine sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Haemophilus Influenzae Type B Vaccine market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Haemophilus Influenzae Type B Vaccine sales, projected growth trends, production technology, application and end-user industry.

Haemophilus Influenzae Type B Vaccine Segment by Company

Takeda Pharmaceuticals Company

Sanofi

Novartis

Merck

Lanzhou Institute of Biologica

GlaxoSmithKline

Walvax Biotechnology

Immunize BC

Haemophilus Influenzae Type B Vaccine Segment by Type

Liquid Combination HIB

Liquid Monovalent HIB

Lyophilized Combination HIB

Lyophilized Monovalent HIB

Haemophilus Influenzae Type B Vaccine Segment by Application

Pharmaceutical and Biotechnology Companies

Hospital

Research Institutions

Academic Institutions

Other

Haemophilus Influenzae Type B Vaccine Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Haemophilus Influenzae Type B Vaccine market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Haemophilus Influenzae Type B Vaccine and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Haemophilus Influenzae Type B Vaccine.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Haemophilus Influenzae Type B Vaccine in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Haemophilus Influenzae Type B Vaccine manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Haemophilus Influenzae Type B Vaccine sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Liquid Combination HIB Major Manufacturers Table 3. Liquid Monovalent HIB Major Manufacturers Table 4. Lyophilized Combination HIB Major Manufacturers Table 5. Lyophilized Monovalent HIB Major Manufacturers Table 6. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. Pharmaceutical and Biotechnology Companies Major Manufacturers Table 8. Hospital Major Manufacturers Table 9. Research Institutions Major Manufacturers Table 10. Academic Institutions Major Manufacturers Table 11. Other Major Manufacturers Table 12. Haemophilus Influenzae Type B Vaccine Industry Trends Table 13. Haemophilus Influenzae Type B Vaccine Industry Drivers Table 14. Haemophilus Influenzae Type B Vaccine Industry Opportunities and Challenges Table 15. Haemophilus Influenzae Type B Vaccine Industry Restraints Table 16. Global Haemophilus Influenzae Type B Vaccine Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 17. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2021-2026) & (US$ Million) Table 18. Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2027-2032) & (US$ Million) Table 19. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2021-2026) Table 20. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2027-2032) Table 21. Global Haemophilus Influenzae Type B Vaccine Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 22. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2021-2026) & (k units) Table 23. Global Haemophilus Influenzae Type B Vaccine Sales by Region (2027-2032) & (k units) Table 24. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2021-2026) Table 25. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2027-2032) Table 26. Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturers (2021-2026) Table 28. Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (US$ Million) & (2021-2026) Table 29. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2021-2026) Table 30. Global Haemophilus Influenzae Type B Vaccine Sales Price (US$/unit) of Manufacturers (2021-2026) Table 31. Global Haemophilus Influenzae Type B Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 32. Global Haemophilus Influenzae Type B Vaccine Key Manufacturers Manufacturing Sites & Headquarters Table 33. Global Haemophilus Influenzae Type B Vaccine Manufacturers, Product Type & Application Table 34. Global Haemophilus Influenzae Type B Vaccine Manufacturers' Establishment Date Table 35. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 36. Global Haemophilus Influenzae Type B Vaccine by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 37. Global Haemophilus Influenzae Type B Vaccine Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 38. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 39. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 40. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2021-2026) Table 41. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2027-2032) Table 42. Global Haemophilus Influenzae Type B Vaccine Sales by Type 2021 VS 2025 VS 2032 (k units) Table 43. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 44. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2027-2032) & (k units) Table 45. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2021-2026) Table 46. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2027-2032) Table 47. Global Haemophilus Influenzae Type B Vaccine Price by Type (2021-2026) & (US$/unit) Table 48. Global Haemophilus Influenzae Type B Vaccine Price by Type (2027-2032) & (US$/unit) Table 49. Global Haemophilus Influenzae Type B Vaccine Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 50. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 51. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 52. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2021-2026) Table 53. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2027-2032) Table 54. Global Haemophilus Influenzae Type B Vaccine Sales by Application 2021 VS 2025 VS 2032 (k units) Table 55. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 56. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2027-2032) & (k units) Table 57. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2021-2026) Table 58. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2027-2032) Table 59. Global Haemophilus Influenzae Type B Vaccine Price by Application (2021-2026) & (US$/unit) Table 60. Global Haemophilus Influenzae Type B Vaccine Price by Application (2027-2032) & (US$/unit) Table 61. Takeda Pharmaceuticals Company Company Information Table 62. Takeda Pharmaceuticals Company Business Overview Table 63. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 64. Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolio Table 65. Takeda Pharmaceuticals Company Recent Development Table 66. Sanofi Company Information Table 67. Sanofi Business Overview Table 68. Sanofi Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 69. Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolio Table 70. Sanofi Recent Development Table 71. Novartis Company Information Table 72. Novartis Business Overview Table 73. Novartis Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 74. Novartis Haemophilus Influenzae Type B Vaccine Product Portfolio Table 75. Novartis Recent Development Table 76. Merck Company Information Table 77. Merck Business Overview Table 78. Merck Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 79. Merck Haemophilus Influenzae Type B Vaccine Product Portfolio Table 80. Merck Recent Development Table 81. Lanzhou Institute of Biologica Company Information Table 82. Lanzhou Institute of Biologica Business Overview Table 83. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 84. Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolio Table 85. Lanzhou Institute of Biologica Recent Development Table 86. GlaxoSmithKline Company Information Table 87. GlaxoSmithKline Business Overview Table 88. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 89. GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolio Table 90. GlaxoSmithKline Recent Development Table 91. Walvax Biotechnology Company Information Table 92. Walvax Biotechnology Business Overview Table 93. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 94. Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolio Table 95. Walvax Biotechnology Recent Development Table 96. Immunize BC Company Information Table 97. Immunize BC Business Overview Table 98. Immunize BC Haemophilus Influenzae Type B Vaccine Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 99. Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolio Table 100. Immunize BC Recent Development Table 101. North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 102. North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 103. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 104. North America Haemophilus Influenzae Type B Vaccine Sales by Type (2027-2032) & (k units) Table 105. North America Haemophilus Influenzae Type B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 106. North America Haemophilus Influenzae Type B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 107. North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 108. North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 109. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 110. North America Haemophilus Influenzae Type B Vaccine Sales by Application (2027-2032) & (k units) Table 111. North America Haemophilus Influenzae Type B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 112. North America Haemophilus Influenzae Type B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 113. North America Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 114. North America Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 115. North America Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 116. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 117. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 118. North America Haemophilus Influenzae Type B Vaccine Sales by Country (2027-2032) & (k units) Table 119. North America Haemophilus Influenzae Type B Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 120. North America Haemophilus Influenzae Type B Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 121. United States Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 122. Canada Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 123. Mexico Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 124. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 125. Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 126. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 127. Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2027-2032) & (k units) Table 128. Europe Haemophilus Influenzae Type B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 129. Europe Haemophilus Influenzae Type B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 130. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 131. Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 132. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 133. Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2027-2032) & (k units) Table 134. Europe Haemophilus Influenzae Type B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 135. Europe Haemophilus Influenzae Type B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 136. Europe Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. Europe Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 138. Europe Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 139. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 140. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 141. Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2027-2032) & (k units) Table 142. Europe Haemophilus Influenzae Type B Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 143. Europe Haemophilus Influenzae Type B Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 144. Germany Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 145. France Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 146. U.K. Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 147. Italy Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 148. Russia Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 149. Spain Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 150. Netherlands Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 151. Switzerland Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 152. Sweden Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 153. Poland Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 154. China Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 155. China Haemophilus Influenzae Type B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 156. China Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 157. China Haemophilus Influenzae Type B Vaccine Sales by Type (2027-2032) & (k units) Table 158. China Haemophilus Influenzae Type B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 159. China Haemophilus Influenzae Type B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 160. China Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 161. China Haemophilus Influenzae Type B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 162. China Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 163. China Haemophilus Influenzae Type B Vaccine Sales by Application (2027-2032) & (k units) Table 164. China Haemophilus Influenzae Type B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 165. China Haemophilus Influenzae Type B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 166. Asia Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 167. Asia Haemophilus Influenzae Type B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 168. Asia Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 169. Asia Haemophilus Influenzae Type B Vaccine Sales by Type (2027-2032) & (k units) Table 170. Asia Haemophilus Influenzae Type B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 171. Asia Haemophilus Influenzae Type B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 172. Asia Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 173. Asia Haemophilus Influenzae Type B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 174. Asia Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 175. Asia Haemophilus Influenzae Type B Vaccine Sales by Application (2027-2032) & (k units) Table 176. Asia Haemophilus Influenzae Type B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 177. Asia Haemophilus Influenzae Type B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 178. Asia Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 179. Asia Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 180. Asia Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 181. Asia Haemophilus Influenzae Type B Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 182. Asia Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 183. Asia Haemophilus Influenzae Type B Vaccine Sales by Country (2027-2032) & (k units) Table 184. Asia Haemophilus Influenzae Type B Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 185. Asia Haemophilus Influenzae Type B Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 186. Japan Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 187. South Korea Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 188. India Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 189. Australia Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 190. Taiwan Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 191. Southeast Asia Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 192. SAMEA Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2026) & (US$ Million) Table 193. SAMEA Haemophilus Influenzae Type B Vaccine Revenue by Type (2027-2032) & (US$ Million) Table 194. SAMEA Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2026) & (k units) Table 195. SAMEA Haemophilus Influenzae Type B Vaccine Sales by Type (2027-2032) & (k units) Table 196. SAMEA Haemophilus Influenzae Type B Vaccine Sales Price by Type (2021-2026) & (US$/unit) Table 197. SAMEA Haemophilus Influenzae Type B Vaccine Sales Price by Type (2027-2032) & (US$/unit) Table 198. SAMEA Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2026) & (US$ Million) Table 199. SAMEA Haemophilus Influenzae Type B Vaccine Revenue by Application (2027-2032) & (US$ Million) Table 200. SAMEA Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2026) & (k units) Table 201. SAMEA Haemophilus Influenzae Type B Vaccine Sales by Application (2027-2032) & (k units) Table 202. SAMEA Haemophilus Influenzae Type B Vaccine Sales Price by Application (2021-2026) & (US$/unit) Table 203. SAMEA Haemophilus Influenzae Type B Vaccine Sales Price by Application (2027-2032) & (US$/unit) Table 204. SAMEA Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 205. SAMEA Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 206. SAMEA Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 207. SAMEA Haemophilus Influenzae Type B Vaccine Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 208. SAMEA Haemophilus Influenzae Type B Vaccine Sales by Country (2021-2026) & (k units) Table 209. SAMEA Haemophilus Influenzae Type B Vaccine Sales by Country (2027-2032) & (k units) Table 210. SAMEA Haemophilus Influenzae Type B Vaccine Sales Price by Country (2021-2026) & (US$/unit) Table 211. SAMEA Haemophilus Influenzae Type B Vaccine Sales Price by Country (2027-2032) & (US$/unit) Table 212. Brazil Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 213. Argentina Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 214. Chile Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 215. Colombia Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 216. Peru Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 217. Saudi Arabia Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 218. Israel Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 219. UAE Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 220. Turkey Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 221. Iran Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 222. Egypt Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Table 223. Key Raw Materials Table 224. Raw Materials Key Suppliers Table 225. Haemophilus Influenzae Type B Vaccine Distributors List Table 226. Haemophilus Influenzae Type B Vaccine Customers List Table 227. Research Programs/Design for This Report Table 228. Authors List of This Report Table 229. Secondary Sources Table 230. Primary Sources List of Figures Figure 1. Haemophilus Influenzae Type B Vaccine Image Figure 2. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Haemophilus Influenzae Type B Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 4. Liquid Combination HIB Image Figure 5. Liquid Monovalent HIB Image Figure 6. Lyophilized Combination HIB Image Figure 7. Lyophilized Monovalent HIB Image Figure 8. Global Haemophilus Influenzae Type B Vaccine Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Haemophilus Influenzae Type B Vaccine Market Size Share 2021 VS 2025 VS 2032 Figure 10. Pharmaceutical and Biotechnology Companies Image Figure 11. Hospital Image Figure 12. Research Institutions Image Figure 13. Academic Institutions Image Figure 14. Other Image Figure 15. Global Haemophilus Influenzae Type B Vaccine Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 16. Global Haemophilus Influenzae Type B Vaccine Revenue (2021-2032) & (US$ Million) Figure 17. Global Haemophilus Influenzae Type B Vaccine Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 18. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region: 2025 Versus 2032 Figure 19. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2021-2032) Figure 20. Global Haemophilus Influenzae Type B Vaccine Sales (2021-2032) & (k units) Figure 21. Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 22. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2021-2032) Figure 23. US & Canada & Mexico Haemophilus Influenzae Type B Vaccine Sales YoY (2021-2032) & (k units) Figure 24. Europe Haemophilus Influenzae Type B Vaccine Sales YoY (2021-2032) & (k units) Figure 25. China Haemophilus Influenzae Type B Vaccine Sales YoY (2021-2032) & (k units) Figure 26. Asia (Excluding China) Haemophilus Influenzae Type B Vaccine Sales YoY (2021-2032) & (k units) Figure 27. South America, Middle East and Africa Haemophilus Influenzae Type B Vaccine Sales YoY (2021-2032) & (k units) Figure 28. Global Haemophilus Influenzae Type B Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 29. Global Haemophilus Influenzae Type B Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 30. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 31. Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 32. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 33. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2021-2032) Figure 34. Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 35. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 36. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2021-2032) Figure 37. Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 38. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 39. Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2021-2032) Figure 40. Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 41. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 42. Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2021-2032) Figure 43. North America Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2021-2032) Figure 44. North America Haemophilus Influenzae Type B Vaccine Sales Share by Type (2021-2032) Figure 45. North America Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2021-2032) Figure 46. North America Haemophilus Influenzae Type B Vaccine Sales Share by Application (2021-2032) Figure 47. North America Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2021-2032) Figure 48. North America Haemophilus Influenzae Type B Vaccine Sales Share by Country (2021-2032) Figure 49. Europe Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2021-2032) Figure 50. Europe Haemophilus Influenzae Type B Vaccine Sales Share by Type (2021-2032) Figure 51. Europe Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2021-2032) Figure 52. Europe Haemophilus Influenzae Type B Vaccine Sales Share by Application (2021-2032) Figure 53. Europe Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2021-2032) Figure 54. Europe Haemophilus Influenzae Type B Vaccine Sales Share by Country (2021-2032) Figure 55. China Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2021-2032) Figure 56. China Haemophilus Influenzae Type B Vaccine Sales Share by Type (2021-2032) Figure 57. China Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2021-2032) Figure 58. China Haemophilus Influenzae Type B Vaccine Sales Share by Application (2021-2032) Figure 59. Asia Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2021-2032) Figure 60. Asia Haemophilus Influenzae Type B Vaccine Sales Share by Type (2021-2032) Figure 61. Asia Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2021-2032) Figure 62. Asia Haemophilus Influenzae Type B Vaccine Sales Share by Application (2021-2032) Figure 63. Asia Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2021-2032) Figure 64. Asia Haemophilus Influenzae Type B Vaccine Sales Share by Country (2021-2032) Figure 65. SAMEA Haemophilus Influenzae Type B Vaccine Revenue Share by Type (2021-2032) Figure 66. SAMEA Haemophilus Influenzae Type B Vaccine Sales Share by Type (2021-2032) Figure 67. SAMEA Haemophilus Influenzae Type B Vaccine Revenue Share by Application (2021-2032) Figure 68. SAMEA Haemophilus Influenzae Type B Vaccine Sales Share by Application (2021-2032) Figure 69. SAMEA Haemophilus Influenzae Type B Vaccine Revenue Share by Country (2021-2032) Figure 70. SAMEA Haemophilus Influenzae Type B Vaccine Sales Share by Country (2021-2032) Figure 71. Haemophilus Influenzae Type B Vaccine Value Chain Figure 72. Manufacturing Cost Structure Figure 73. Haemophilus Influenzae Type B Vaccine Production Mode & Process Figure 74. Direct Comparison with Distribution Share Figure 75. Distributors Profiles Figure 76. Years Considered Figure 77. Research Process Figure 78. Key Executives Interviewed

Scope & coverage.

Types
  • Liquid Combination HIB
  • Liquid Monovalent HIB
  • Lyophilized Combination HIB
  • Lyophilized Monovalent HIB
Applications
  • Pharmaceutical and Biotechnology Companies
  • Hospital
  • Research Institutions
  • Academic Institutions
  • Other
Companies covered
  • Takeda Pharmaceuticals Company
  • Sanofi
  • Novartis
  • Merck
  • Lanzhou Institute of Biologica
  • GlaxoSmithKline
  • Walvax Biotechnology
  • Immunize BC

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Haemophilus Influenzae Type B Vaccine Market by Type
  3. 1.2.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Liquid Combination HIB
  5. 1.2.3 Liquid Monovalent HIB
  6. 1.2.4 Lyophilized Combination HIB
  7. 1.2.5 Lyophilized Monovalent HIB
  8. 1.3 Haemophilus Influenzae Type B Vaccine Market by Application
  9. 1.3.1 Global Haemophilus Influenzae Type B Vaccine Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 Pharmaceutical and Biotechnology Companies
  11. 1.3.3 Hospital
  12. 1.3.4 Research Institutions
  13. 1.3.5 Academic Institutions
  14. 1.3.6 Other
  15. 1.4 Assumptions and Limitations
  16. 1.5 Study Goals and Objectives
2 Haemophilus Influenzae Type B Vaccine Market Dynamics
  1. 2.1 Haemophilus Influenzae Type B Vaccine Industry Trends
  2. 2.2 Haemophilus Influenzae Type B Vaccine Industry Drivers
  3. 2.3 Haemophilus Influenzae Type B Vaccine Industry Opportunities and Challenges
  4. 2.4 Haemophilus Influenzae Type B Vaccine Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Haemophilus Influenzae Type B Vaccine Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region
  3. 3.2.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2021-2026)
  5. 3.2.3 Global Haemophilus Influenzae Type B Vaccine Revenue by Region (2027-2032)
  6. 3.2.4 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Haemophilus Influenzae Type B Vaccine Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Haemophilus Influenzae Type B Vaccine Sales by Region
  9. 3.4.1 Global Haemophilus Influenzae Type B Vaccine Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Haemophilus Influenzae Type B Vaccine Sales by Region (2021-2026)
  11. 3.4.3 Global Haemophilus Influenzae Type B Vaccine Sales by Region (2027-2032)
  12. 3.4.4 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers
  2. 4.1.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Haemophilus Influenzae Type B Vaccine Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers
  6. 4.2.1 Global Haemophilus Influenzae Type B Vaccine Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Haemophilus Influenzae Type B Vaccine Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Haemophilus Influenzae Type B Vaccine Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Haemophilus Influenzae Type B Vaccine Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Haemophilus Influenzae Type B Vaccine Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Haemophilus Influenzae Type B Vaccine Manufacturers, Product Type & Application
  13. 4.7 Global Haemophilus Influenzae Type B Vaccine Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Haemophilus Influenzae Type B Vaccine Market CR5 and HHI
  16. 4.8.2 2025 Haemophilus Influenzae Type B Vaccine Tier 1, Tier 2, and Tier 3
5 Haemophilus Influenzae Type B Vaccine Market by Type
  1. 5.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Type
  2. 5.1.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Haemophilus Influenzae Type B Vaccine Sales by Type
  6. 5.2.1 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Type (2021-2032)
  9. 5.3 Global Haemophilus Influenzae Type B Vaccine Price by Type
6 Haemophilus Influenzae Type B Vaccine Market by Application
  1. 6.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Application
  2. 6.1.1 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Haemophilus Influenzae Type B Vaccine Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Haemophilus Influenzae Type B Vaccine Sales by Application
  6. 6.2.1 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Haemophilus Influenzae Type B Vaccine Sales Market Share by Application (2021-2032)
  9. 6.3 Global Haemophilus Influenzae Type B Vaccine Price by Application
7 Company Profiles
  1. 7.1 Takeda Pharmaceuticals Company
  2. 7.1.1 Takeda Pharmaceuticals Company Company Information
  3. 7.1.2 Takeda Pharmaceuticals Company Business Overview
  4. 7.1.3 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Takeda Pharmaceuticals Company Haemophilus Influenzae Type B Vaccine Product Portfolio
  6. 7.1.5 Takeda Pharmaceuticals Company Recent Developments
  7. 7.2 Sanofi
  8. 7.2.1 Sanofi Company Information
  9. 7.2.2 Sanofi Business Overview
  10. 7.2.3 Sanofi Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Sanofi Haemophilus Influenzae Type B Vaccine Product Portfolio
  12. 7.2.5 Sanofi Recent Developments
  13. 7.3 Novartis
  14. 7.3.1 Novartis Company Information
  15. 7.3.2 Novartis Business Overview
  16. 7.3.3 Novartis Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Novartis Haemophilus Influenzae Type B Vaccine Product Portfolio
  18. 7.3.5 Novartis Recent Developments
  19. 7.4 Merck
  20. 7.4.1 Merck Company Information
  21. 7.4.2 Merck Business Overview
  22. 7.4.3 Merck Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Merck Haemophilus Influenzae Type B Vaccine Product Portfolio
  24. 7.4.5 Merck Recent Developments
  25. 7.5 Lanzhou Institute of Biologica
  26. 7.5.1 Lanzhou Institute of Biologica Company Information
  27. 7.5.2 Lanzhou Institute of Biologica Business Overview
  28. 7.5.3 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Lanzhou Institute of Biologica Haemophilus Influenzae Type B Vaccine Product Portfolio
  30. 7.5.5 Lanzhou Institute of Biologica Recent Developments
  31. 7.6 GlaxoSmithKline
  32. 7.6.1 GlaxoSmithKline Company Information
  33. 7.6.2 GlaxoSmithKline Business Overview
  34. 7.6.3 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 GlaxoSmithKline Haemophilus Influenzae Type B Vaccine Product Portfolio
  36. 7.6.5 GlaxoSmithKline Recent Developments
  37. 7.7 Walvax Biotechnology
  38. 7.7.1 Walvax Biotechnology Company Information
  39. 7.7.2 Walvax Biotechnology Business Overview
  40. 7.7.3 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Walvax Biotechnology Haemophilus Influenzae Type B Vaccine Product Portfolio
  42. 7.7.5 Walvax Biotechnology Recent Developments
  43. 7.8 Immunize BC
  44. 7.8.1 Immunize BC Company Information
  45. 7.8.2 Immunize BC Business Overview
  46. 7.8.3 Immunize BC Haemophilus Influenzae Type B Vaccine Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Immunize BC Haemophilus Influenzae Type B Vaccine Product Portfolio
  48. 7.8.5 Immunize BC Recent Developments
8 North America
  1. 8.1 North America Haemophilus Influenzae Type B Vaccine Market Size by Type
  2. 8.1.1 North America Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2032)
  3. 8.1.2 North America Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2032)
  4. 8.1.3 North America Haemophilus Influenzae Type B Vaccine Price by Type (2021-2032)
  5. 8.2 North America Haemophilus Influenzae Type B Vaccine Market Size by Application
  6. 8.2.1 North America Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2032)
  7. 8.2.2 North America Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2032)
  8. 8.2.3 North America Haemophilus Influenzae Type B Vaccine Price by Application (2021-2032)
  9. 8.3 North America Haemophilus Influenzae Type B Vaccine Market Size by Country
  10. 8.3.1 North America Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Haemophilus Influenzae Type B Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Haemophilus Influenzae Type B Vaccine Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Haemophilus Influenzae Type B Vaccine Market Size by Type
  2. 9.1.1 Europe Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2032)
  3. 9.1.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2032)
  4. 9.1.3 Europe Haemophilus Influenzae Type B Vaccine Price by Type (2021-2032)
  5. 9.2 Europe Haemophilus Influenzae Type B Vaccine Market Size by Application
  6. 9.2.1 Europe Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2032)
  7. 9.2.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2032)
  8. 9.2.3 Europe Haemophilus Influenzae Type B Vaccine Price by Application (2021-2032)
  9. 9.3 Europe Haemophilus Influenzae Type B Vaccine Market Size by Country
  10. 9.3.1 Europe Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Haemophilus Influenzae Type B Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Haemophilus Influenzae Type B Vaccine Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Haemophilus Influenzae Type B Vaccine Market Size by Type
  2. 10.1.1 China Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2032)
  3. 10.1.2 China Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2032)
  4. 10.1.3 China Haemophilus Influenzae Type B Vaccine Price by Type (2021-2032)
  5. 10.2 China Haemophilus Influenzae Type B Vaccine Market Size by Application
  6. 10.2.1 China Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2032)
  7. 10.2.2 China Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2032)
  8. 10.2.3 China Haemophilus Influenzae Type B Vaccine Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Haemophilus Influenzae Type B Vaccine Market Size by Type
  2. 11.1.1 Asia Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2032)
  3. 11.1.2 Asia Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2032)
  4. 11.1.3 Asia Haemophilus Influenzae Type B Vaccine Price by Type (2021-2032)
  5. 11.2 Asia Haemophilus Influenzae Type B Vaccine Market Size by Application
  6. 11.2.1 Asia Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2032)
  7. 11.2.2 Asia Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2032)
  8. 11.2.3 Asia Haemophilus Influenzae Type B Vaccine Price by Application (2021-2032)
  9. 11.3 Asia Haemophilus Influenzae Type B Vaccine Market Size by Country
  10. 11.3.1 Asia Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Haemophilus Influenzae Type B Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Haemophilus Influenzae Type B Vaccine Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Haemophilus Influenzae Type B Vaccine Market Size by Type
  2. 12.1.1 SAMEA Haemophilus Influenzae Type B Vaccine Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Haemophilus Influenzae Type B Vaccine Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Haemophilus Influenzae Type B Vaccine Price by Type (2021-2032)
  5. 12.2 SAMEA Haemophilus Influenzae Type B Vaccine Market Size by Application
  6. 12.2.1 SAMEA Haemophilus Influenzae Type B Vaccine Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Haemophilus Influenzae Type B Vaccine Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Haemophilus Influenzae Type B Vaccine Price by Application (2021-2032)
  9. 12.3 SAMEA Haemophilus Influenzae Type B Vaccine Market Size by Country
  10. 12.3.1 SAMEA Haemophilus Influenzae Type B Vaccine Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Haemophilus Influenzae Type B Vaccine Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Haemophilus Influenzae Type B Vaccine Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Haemophilus Influenzae Type B Vaccine Value Chain Analysis
  2. 13.1.1 Haemophilus Influenzae Type B Vaccine Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Haemophilus Influenzae Type B Vaccine Production Mode & Process
  6. 13.2 Haemophilus Influenzae Type B Vaccine Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Haemophilus Influenzae Type B Vaccine Distributors
  9. 13.2.3 Haemophilus Influenzae Type B Vaccine Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst